Photodynamic Therapy Enhanced by Gene Therapy Shows Promise for Cancer Treatment

Strategic Insights -

Researchers from the Third Military Medical University in Chongqing, People's Republic of China, have made significant strides in the development of photodynamic therapy (PDT) for cancer treatment. By combining PDT with gene therapy, targeted at the apurinic/apyrimidinic endonuclease 1 (APE1) protein, they have shown improved efficacy in killing cancer cells. The study focused on non-small cell lung cancer (NSCLC) cells, and the results demonstrated that the combined approach enhanced the killing effect of PDT on these cells, both in vitro and in vivo.

Key Takeaways:

  • Photodynamic therapy (PDT) combined with gene therapy targeting APE1 protein shows promise for cancer treatment, particularly for non-small cell lung cancer (NSCLC).
  • APE1 protein plays a crucial role in DNA repair and redox regulation of gene transcription, making it an attractive target for PDT combined gene therapy.
  • The adenovirus-mediated APE1 silencing strategy used in the study effectively inhibited APE1 protein upregulation induced by PDT, resulting in increased cell apoptosis after photoirradiation.
  • The combination of PDT and APE1-targeted gene therapy suppressed DNA repair capacity for single-strand breaks and abolished the activation of stress-related transcription factors such as hypoxia-induced factor (HIF)-1, leading to increased cell apoptosis.
  • The study showed that the treatment of NSCLC cells with APE1-targeted gene therapy combined with PDT resulted in significant tumor suppression efficacy, both in vitro and in vivo.

Statistics:

  • The study used the non-small cell lung cancer cell line A549, which was infected with the adenovirus vector Ad5/F35-shAPE1 to silence the APE1 protein.
  • The adenovirus vector Ad5/F35-shAPE1 was shown to express the APE1 siRNA effectively, resulting in a significant decrease in APE1 protein expression.
  • The combination of PDT and APE1-targeted gene therapy resulted in a 30% increase in cell killing compared to PDT alone.
  • The treatment of NSCLC cells with APE1-targeted gene therapy combined with PDT resulted in a 40% reduction in tumor size, compared to PDT alone.

Sources:

  • Yang, Z.Z., et al. (2009). Knock down of the dual functional protein apurinic/ap yrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model. Cancer Science, 100(11), 180-187.
  • Cancer Gene Therapy Week (2010). Photodynamic Therapy Enhanced by Gene Therapy Shows Promise for Cancer Treatment. Cancer Gene Therapy Week, via NewsRx.com.